APO Research
Talk to an analyst

APO RESEARCH · REPORT

Influenza Drugs and Vaccines

Compare research editions
View pricing & licenses

Selected research

Industry Research

Influenza Drugs and Vaccines Industry Research Report 2026

26 December 2025148 pages

Choose your research edition.

Industry ResearchInfluenza Drugs and Vaccines Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Influenza Drugs and Vaccines Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Influenza Drugs and Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Influenza Drugs and Vaccines Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Influenza Drugs and Vaccines Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Influenza Drugs and Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Influenza Drugs and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Influenza Drugs and Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Influenza Drugs and Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Influenza Drugs and Vaccines include CSL, Alvogen, AstraZeneca, BioCryst Pharmaceuticals, Bristol Myers Squibb, Celgene, Emergent Biosolutions, GlaxoSmithKline and Hulan Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Influenza Drugs and Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Influenza Drugs and Vaccines Market by Company

CSL

Alvogen

AstraZeneca

BioCryst Pharmaceuticals

Bristol Myers Squibb

Celgene

Emergent Biosolutions

GlaxoSmithKline

Hulan Bio

Protein Sciences Corporation

Seqirus

Serum Institute of India

Viatris

Beike Bio

Bayer

Pfizer

Jiangsu GDK

Sinovac

Eli Lilly

Roche

Novartis

Sanofi

Changchun Institute of Biological

Influenza Drugs and Vaccines Segment by Type

Influenza Drugs

Influenza Vaccines

Influenza Drugs and Vaccines Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Influenza Drugs and Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Influenza Drugs and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Influenza Drugs and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Influenza Drugs and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Influenza Drugs and Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Influenza Drugs and Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Influenza Drugs and Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Influenza Drugs and Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Influenza Drugs and Vaccines Sales (Tons) of Manufacturers (2021-2026) Table 7. Global Influenza Drugs and Vaccines Sales Market Share by Manufacturers (2021-2026) Table 8. Global Influenza Drugs and Vaccines Revenue of Manufacturers (2021-2026) Table 9. Global Influenza Drugs and Vaccines Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Influenza Drugs and Vaccines Average Price (US$/Kg) of Manufacturers (2021-2026) Table 11. Global Influenza Drugs and Vaccines Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Influenza Drugs and Vaccines, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Influenza Drugs and Vaccines, Product Type & Application Table 14. Global Influenza Drugs and Vaccines Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Influenza Drugs and Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. CSL Company Information Table 19. CSL Business Overview Table 20. CSL Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 21. CSL Influenza Drugs and Vaccines Product Portfolio Table 22. CSL Recent Developments Table 23. Alvogen Company Information Table 24. Alvogen Business Overview Table 25. Alvogen Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 26. Alvogen Influenza Drugs and Vaccines Product Portfolio Table 27. Alvogen Recent Developments Table 28. AstraZeneca Company Information Table 29. AstraZeneca Business Overview Table 30. AstraZeneca Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 31. AstraZeneca Influenza Drugs and Vaccines Product Portfolio Table 32. AstraZeneca Recent Developments Table 33. BioCryst Pharmaceuticals Company Information Table 34. BioCryst Pharmaceuticals Business Overview Table 35. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 36. BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Portfolio Table 37. BioCryst Pharmaceuticals Recent Developments Table 38. Bristol Myers Squibb Company Information Table 39. Bristol Myers Squibb Business Overview Table 40. Bristol Myers Squibb Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 41. Bristol Myers Squibb Influenza Drugs and Vaccines Product Portfolio Table 42. Bristol Myers Squibb Recent Developments Table 43. Celgene Company Information Table 44. Celgene Business Overview Table 45. Celgene Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 46. Celgene Influenza Drugs and Vaccines Product Portfolio Table 47. Celgene Recent Developments Table 48. Emergent Biosolutions Company Information Table 49. Emergent Biosolutions Business Overview Table 50. Emergent Biosolutions Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 51. Emergent Biosolutions Influenza Drugs and Vaccines Product Portfolio Table 52. Emergent Biosolutions Recent Developments Table 53. GlaxoSmithKline Company Information Table 54. GlaxoSmithKline Business Overview Table 55. GlaxoSmithKline Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 56. GlaxoSmithKline Influenza Drugs and Vaccines Product Portfolio Table 57. GlaxoSmithKline Recent Developments Table 58. Hulan Bio Company Information Table 59. Hulan Bio Business Overview Table 60. Hulan Bio Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 61. Hulan Bio Influenza Drugs and Vaccines Product Portfolio Table 62. Hulan Bio Recent Developments Table 63. Protein Sciences Corporation Company Information Table 64. Protein Sciences Corporation Business Overview Table 65. Protein Sciences Corporation Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 66. Protein Sciences Corporation Influenza Drugs and Vaccines Product Portfolio Table 67. Protein Sciences Corporation Recent Developments Table 68. Seqirus Company Information Table 69. Seqirus Business Overview Table 70. Seqirus Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 71. Seqirus Influenza Drugs and Vaccines Product Portfolio Table 72. Seqirus Recent Developments Table 73. Serum Institute of India Company Information Table 74. Serum Institute of India Business Overview Table 75. Serum Institute of India Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 76. Serum Institute of India Influenza Drugs and Vaccines Product Portfolio Table 77. Serum Institute of India Recent Developments Table 78. Viatris Company Information Table 79. Viatris Business Overview Table 80. Viatris Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 81. Viatris Influenza Drugs and Vaccines Product Portfolio Table 82. Viatris Recent Developments Table 83. Beike Bio Company Information Table 84. Beike Bio Business Overview Table 85. Beike Bio Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 86. Beike Bio Influenza Drugs and Vaccines Product Portfolio Table 87. Beike Bio Recent Developments Table 88. Bayer Company Information Table 89. Bayer Business Overview Table 90. Bayer Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 91. Bayer Influenza Drugs and Vaccines Product Portfolio Table 92. Bayer Recent Developments Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 96. Pfizer Influenza Drugs and Vaccines Product Portfolio Table 97. Pfizer Recent Developments Table 98. Jiangsu GDK Company Information Table 99. Jiangsu GDK Business Overview Table 100. Jiangsu GDK Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 101. Jiangsu GDK Influenza Drugs and Vaccines Product Portfolio Table 102. Jiangsu GDK Recent Developments Table 103. Sinovac Company Information Table 104. Sinovac Business Overview Table 105. Sinovac Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 106. Sinovac Influenza Drugs and Vaccines Product Portfolio Table 107. Sinovac Recent Developments Table 108. Eli Lilly Company Information Table 109. Eli Lilly Business Overview Table 110. Eli Lilly Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 111. Eli Lilly Influenza Drugs and Vaccines Product Portfolio Table 112. Eli Lilly Recent Developments Table 113. Roche Company Information Table 114. Roche Business Overview Table 115. Roche Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 116. Roche Influenza Drugs and Vaccines Product Portfolio Table 117. Roche Recent Developments Table 118. Novartis Company Information Table 119. Novartis Business Overview Table 120. Novartis Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 121. Novartis Influenza Drugs and Vaccines Product Portfolio Table 122. Novartis Recent Developments Table 123. Sanofi Company Information Table 124. Sanofi Business Overview Table 125. Sanofi Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 126. Sanofi Influenza Drugs and Vaccines Product Portfolio Table 127. Sanofi Recent Developments Table 128. Changchun Institute of Biological Company Information Table 129. Changchun Institute of Biological Business Overview Table 130. Changchun Institute of Biological Influenza Drugs and Vaccines Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 131. Changchun Institute of Biological Influenza Drugs and Vaccines Product Portfolio Table 132. Changchun Institute of Biological Recent Developments Table 133. Global Influenza Drugs and Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 134. Global Influenza Drugs and Vaccines Sales by Region (2021-2026) & (Tons) Table 135. Global Influenza Drugs and Vaccines Sales Market Share by Region (2021-2026) Table 136. Global Influenza Drugs and Vaccines Sales by Region (2027-2032) & (Tons) Table 137. Global Influenza Drugs and Vaccines Sales Market Share by Region (2027-2032) Table 138. Global Influenza Drugs and Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 139. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2021-2026) Table 140. Global Influenza Drugs and Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 141. Global Influenza Drugs and Vaccines Revenue Market Share by Region (2027-2032) Table 142. North America Influenza Drugs and Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. North America Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 144. North America Influenza Drugs and Vaccines Sales by Country (2027-2032) & (Tons) Table 145. North America Influenza Drugs and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 146. North America Influenza Drugs and Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 147. Europe Influenza Drugs and Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Europe Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 149. Europe Influenza Drugs and Vaccines Sales by Country (2027-2032) & (Tons) Table 150. Europe Influenza Drugs and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 151. Europe Influenza Drugs and Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 152. Asia Pacific Influenza Drugs and Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. Asia Pacific Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 154. Asia Pacific Influenza Drugs and Vaccines Sales by Country (2027-2032) & (Tons) Table 155. Asia Pacific Influenza Drugs and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 156. Asia Pacific Influenza Drugs and Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 157. South America Influenza Drugs and Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. South America Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 159. South America Influenza Drugs and Vaccines Sales by Country (2027-2032) & (Tons) Table 160. South America Influenza Drugs and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 161. South America Influenza Drugs and Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 162. Middle East and Africa Influenza Drugs and Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 163. Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2021-2026) & (Tons) Table 164. Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2027-2032) & (Tons) Table 165. Middle East and Africa Influenza Drugs and Vaccines Revenue by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Influenza Drugs and Vaccines Revenue by Country (2027-2032) & (US$ Million) Table 167. Global Influenza Drugs and Vaccines Sales by Type (2021-2026) & (Tons) Table 168. Global Influenza Drugs and Vaccines Sales by Type (2027-2032) & (Tons) Table 169. Global Influenza Drugs and Vaccines Sales Market Share by Type (2021-2026) Table 170. Global Influenza Drugs and Vaccines Sales Market Share by Type (2027-2032) Table 171. Global Influenza Drugs and Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 172. Global Influenza Drugs and Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 173. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2021-2026) Table 174. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2027-2032) Table 175. Global Influenza Drugs and Vaccines Price by Type (2021-2026) & (US$/Kg) Table 176. Global Influenza Drugs and Vaccines Price by Type (2027-2032) & (US$/Kg) Table 177. Global Influenza Drugs and Vaccines Sales by Application (2021-2026) & (Tons) Table 178. Global Influenza Drugs and Vaccines Sales by Application (2027-2032) & (Tons) Table 179. Global Influenza Drugs and Vaccines Sales Market Share by Application (2021-2026) Table 180. Global Influenza Drugs and Vaccines Sales Market Share by Application (2027-2032) Table 181. Global Influenza Drugs and Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 182. Global Influenza Drugs and Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 183. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2021-2026) Table 184. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2027-2032) Table 185. Global Influenza Drugs and Vaccines Price by Application (2021-2026) & (US$/Kg) Table 186. Global Influenza Drugs and Vaccines Price by Application (2027-2032) & (US$/Kg) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Influenza Drugs and Vaccines Distributors List Table 190. Influenza Drugs and Vaccines Customers List Table 191. Influenza Drugs and Vaccines Industry Trends Table 192. Influenza Drugs and Vaccines Industry Drivers Table 193. Influenza Drugs and Vaccines Industry Restraints Table 194. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Influenza Drugs and Vaccines Product Image Figure 5. Global Influenza Drugs and Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Influenza Drugs and Vaccines Market Size (2021-2032) & (US$ Million) Figure 7. Global Influenza Drugs and Vaccines Sales (2021-2032) & (Tons) Figure 8. Global Influenza Drugs and Vaccines Average Price (US$/Kg) & (2021-2032) Figure 9. Influenza Drugs Product Image Figure 10. Influenza Vaccines Product Image Figure 11. Retail Pharmacy Product Image Figure 12. Online Pharmacy Product Image Figure 13. Hospital Pharmacy Product Image Figure 14. Global Influenza Drugs and Vaccines Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Influenza Drugs and Vaccines, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Influenza Drugs and Vaccines Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Influenza Drugs and Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Influenza Drugs and Vaccines Sales by Region in 2025 Figure 20. Global Influenza Drugs and Vaccines Revenue by Region in 2025 Figure 21. North America Influenza Drugs and Vaccines Market Size by Country in 2025 Figure 22. North America Influenza Drugs and Vaccines Sales Market Share by Country (2021-2032) Figure 23. North America Influenza Drugs and Vaccines Revenue Market Share by Country (2021-2032) Figure 24. United States Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Influenza Drugs and Vaccines Market Size by Country in 2025 Figure 28. Europe Influenza Drugs and Vaccines Sales Market Share by Country (2021-2032) Figure 29. Europe Influenza Drugs and Vaccines Revenue Market Share by Country (2021-2032) Figure 30. Germany Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Influenza Drugs and Vaccines Market Size by Country in 2025 Figure 41. Asia Pacific Influenza Drugs and Vaccines Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Influenza Drugs and Vaccines Revenue Market Share by Country (2021-2032) Figure 43. China Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Influenza Drugs and Vaccines Market Size by Country in 2025 Figure 52. South America Influenza Drugs and Vaccines Sales Market Share by Country (2021-2032) Figure 53. South America Influenza Drugs and Vaccines Revenue Market Share by Country (2021-2032) Figure 54. Brazil Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Influenza Drugs and Vaccines Market Size by Country in 2025 Figure 58. Middle East and Africa Influenza Drugs and Vaccines Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Influenza Drugs and Vaccines Revenue Market Share by Country (2021-2032) Figure 60. Egypt Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Influenza Drugs and Vaccines Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Influenza Drugs and Vaccines Sales Market Share by Type (2021-2032) Figure 66. Global Influenza Drugs and Vaccines Revenue Market Share by Type (2021-2032) Figure 67. Global Influenza Drugs and Vaccines Price (US$/Kg) by Type (2021-2032) Figure 68. Global Influenza Drugs and Vaccines Sales Market Share by Application (2021-2032) Figure 69. Global Influenza Drugs and Vaccines Revenue Market Share by Application (2021-2032) Figure 70. Global Influenza Drugs and Vaccines Price (US$/Kg) by Application (2021-2032) Figure 71. Influenza Drugs and Vaccines Value Chain Figure 72. Influenza Drugs and Vaccines Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Influenza Drugs and Vaccines Industry Opportunities and Challenges

Scope & coverage.

Types
  • Influenza Drugs
  • Influenza Vaccines
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • CSL
  • Alvogen
  • AstraZeneca
  • BioCryst Pharmaceuticals
  • Bristol Myers Squibb
  • Celgene
  • Emergent Biosolutions
  • GlaxoSmithKline
  • Hulan Bio
  • Protein Sciences Corporation
  • Seqirus
  • Serum Institute of India
  • Viatris
  • Beike Bio
  • Bayer
  • Pfizer
  • Jiangsu GDK
  • Sinovac
  • Eli Lilly
  • Roche
  • Novartis
  • Sanofi
  • Changchun Institute of Biological

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Influenza Drugs and Vaccines Market Size (2021-2032)
  4. 2.2.2 Global Influenza Drugs and Vaccines Sales (2021-2032)
  5. 2.2.3 Global Influenza Drugs and Vaccines Market Average Price (2021-2032)
  6. 2.3 Influenza Drugs and Vaccines by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Influenza Drugs
  9. 2.3.3 Influenza Vaccines
  10. 2.4 Influenza Drugs and Vaccines by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Retail Pharmacy
  13. 2.4.3 Online Pharmacy
  14. 2.4.4 Hospital Pharmacy
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Influenza Drugs and Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Influenza Drugs and Vaccines Sales (Tons) of Manufacturers (2021-2026)
  3. 3.3 Global Influenza Drugs and Vaccines Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Influenza Drugs and Vaccines Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Influenza Drugs and Vaccines Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Influenza Drugs and Vaccines, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Influenza Drugs and Vaccines, Product Type & Application
  8. 3.8 Global Manufacturers of Influenza Drugs and Vaccines, Established Date
  9. 3.9 Global Influenza Drugs and Vaccines Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 CSL
  2. 4.1.1 CSL Company Information
  3. 4.1.2 CSL Business Overview
  4. 4.1.3 CSL Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 CSL Influenza Drugs and Vaccines Product Portfolio
  6. 4.1.5 CSL Recent Developments
  7. 4.2 Alvogen
  8. 4.2.1 Alvogen Company Information
  9. 4.2.2 Alvogen Business Overview
  10. 4.2.3 Alvogen Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Alvogen Influenza Drugs and Vaccines Product Portfolio
  12. 4.2.5 Alvogen Recent Developments
  13. 4.3 AstraZeneca
  14. 4.3.1 AstraZeneca Company Information
  15. 4.3.2 AstraZeneca Business Overview
  16. 4.3.3 AstraZeneca Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 AstraZeneca Influenza Drugs and Vaccines Product Portfolio
  18. 4.3.5 AstraZeneca Recent Developments
  19. 4.4 BioCryst Pharmaceuticals
  20. 4.4.1 BioCryst Pharmaceuticals Company Information
  21. 4.4.2 BioCryst Pharmaceuticals Business Overview
  22. 4.4.3 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 BioCryst Pharmaceuticals Influenza Drugs and Vaccines Product Portfolio
  24. 4.4.5 BioCryst Pharmaceuticals Recent Developments
  25. 4.5 Bristol Myers Squibb
  26. 4.5.1 Bristol Myers Squibb Company Information
  27. 4.5.2 Bristol Myers Squibb Business Overview
  28. 4.5.3 Bristol Myers Squibb Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Bristol Myers Squibb Influenza Drugs and Vaccines Product Portfolio
  30. 4.5.5 Bristol Myers Squibb Recent Developments
  31. 4.6 Celgene
  32. 4.6.1 Celgene Company Information
  33. 4.6.2 Celgene Business Overview
  34. 4.6.3 Celgene Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Celgene Influenza Drugs and Vaccines Product Portfolio
  36. 4.6.5 Celgene Recent Developments
  37. 4.7 Emergent Biosolutions
  38. 4.7.1 Emergent Biosolutions Company Information
  39. 4.7.2 Emergent Biosolutions Business Overview
  40. 4.7.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Emergent Biosolutions Influenza Drugs and Vaccines Product Portfolio
  42. 4.7.5 Emergent Biosolutions Recent Developments
  43. 4.8 GlaxoSmithKline
  44. 4.8.1 GlaxoSmithKline Company Information
  45. 4.8.2 GlaxoSmithKline Business Overview
  46. 4.8.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 GlaxoSmithKline Influenza Drugs and Vaccines Product Portfolio
  48. 4.8.5 GlaxoSmithKline Recent Developments
  49. 4.9 Hulan Bio
  50. 4.9.1 Hulan Bio Company Information
  51. 4.9.2 Hulan Bio Business Overview
  52. 4.9.3 Hulan Bio Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Hulan Bio Influenza Drugs and Vaccines Product Portfolio
  54. 4.9.5 Hulan Bio Recent Developments
  55. 4.10 Protein Sciences Corporation
  56. 4.10.1 Protein Sciences Corporation Company Information
  57. 4.10.2 Protein Sciences Corporation Business Overview
  58. 4.10.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Protein Sciences Corporation Influenza Drugs and Vaccines Product Portfolio
  60. 4.10.5 Protein Sciences Corporation Recent Developments
  61. 4.11 Seqirus
  62. 4.11.1 Seqirus Company Information
  63. 4.11.2 Seqirus Business Overview
  64. 4.11.3 Seqirus Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Seqirus Influenza Drugs and Vaccines Product Portfolio
  66. 4.11.5 Seqirus Recent Developments
  67. 4.12 Serum Institute of India
  68. 4.12.1 Serum Institute of India Company Information
  69. 4.12.2 Serum Institute of India Business Overview
  70. 4.12.3 Serum Institute of India Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Serum Institute of India Influenza Drugs and Vaccines Product Portfolio
  72. 4.12.5 Serum Institute of India Recent Developments
  73. 4.13 Viatris
  74. 4.13.1 Viatris Company Information
  75. 4.13.2 Viatris Business Overview
  76. 4.13.3 Viatris Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Viatris Influenza Drugs and Vaccines Product Portfolio
  78. 4.13.5 Viatris Recent Developments
  79. 4.14 Beike Bio
  80. 4.14.1 Beike Bio Company Information
  81. 4.14.2 Beike Bio Business Overview
  82. 4.14.3 Beike Bio Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Beike Bio Influenza Drugs and Vaccines Product Portfolio
  84. 4.14.5 Beike Bio Recent Developments
  85. 4.15 Bayer
  86. 4.15.1 Bayer Company Information
  87. 4.15.2 Bayer Business Overview
  88. 4.15.3 Bayer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Bayer Influenza Drugs and Vaccines Product Portfolio
  90. 4.15.5 Bayer Recent Developments
  91. 4.16 Pfizer
  92. 4.16.1 Pfizer Company Information
  93. 4.16.2 Pfizer Business Overview
  94. 4.16.3 Pfizer Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Pfizer Influenza Drugs and Vaccines Product Portfolio
  96. 4.16.5 Pfizer Recent Developments
  97. 4.17 Jiangsu GDK
  98. 4.17.1 Jiangsu GDK Company Information
  99. 4.17.2 Jiangsu GDK Business Overview
  100. 4.17.3 Jiangsu GDK Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Jiangsu GDK Influenza Drugs and Vaccines Product Portfolio
  102. 4.17.5 Jiangsu GDK Recent Developments
  103. 4.18 Sinovac
  104. 4.18.1 Sinovac Company Information
  105. 4.18.2 Sinovac Business Overview
  106. 4.18.3 Sinovac Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Sinovac Influenza Drugs and Vaccines Product Portfolio
  108. 4.18.5 Sinovac Recent Developments
  109. 4.19 Eli Lilly
  110. 4.19.1 Eli Lilly Company Information
  111. 4.19.2 Eli Lilly Business Overview
  112. 4.19.3 Eli Lilly Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Eli Lilly Influenza Drugs and Vaccines Product Portfolio
  114. 4.19.5 Eli Lilly Recent Developments
  115. 4.20 Roche
  116. 4.20.1 Roche Company Information
  117. 4.20.2 Roche Business Overview
  118. 4.20.3 Roche Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Roche Influenza Drugs and Vaccines Product Portfolio
  120. 4.20.5 Roche Recent Developments
  121. 4.21 Novartis
  122. 4.21.1 Novartis Company Information
  123. 4.21.2 Novartis Business Overview
  124. 4.21.3 Novartis Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Novartis Influenza Drugs and Vaccines Product Portfolio
  126. 4.21.5 Novartis Recent Developments
  127. 4.22 Sanofi
  128. 4.22.1 Sanofi Company Information
  129. 4.22.2 Sanofi Business Overview
  130. 4.22.3 Sanofi Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Sanofi Influenza Drugs and Vaccines Product Portfolio
  132. 4.22.5 Sanofi Recent Developments
  133. 4.23 Changchun Institute of Biological
  134. 4.23.1 Changchun Institute of Biological Company Information
  135. 4.23.2 Changchun Institute of Biological Business Overview
  136. 4.23.3 Changchun Institute of Biological Influenza Drugs and Vaccines Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Changchun Institute of Biological Influenza Drugs and Vaccines Product Portfolio
  138. 4.23.5 Changchun Institute of Biological Recent Developments
5 Global Influenza Drugs and Vaccines Market Scenario by Region
  1. 5.1 Global Influenza Drugs and Vaccines Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Influenza Drugs and Vaccines Sales by Region: 2021-2032
  3. 5.2.1 Global Influenza Drugs and Vaccines Sales by Region: 2021-2026
  4. 5.2.2 Global Influenza Drugs and Vaccines Sales by Region: 2027-2032
  5. 5.3 Global Influenza Drugs and Vaccines Revenue by Region: 2021-2032
  6. 5.3.1 Global Influenza Drugs and Vaccines Revenue by Region: 2021-2026
  7. 5.3.2 Global Influenza Drugs and Vaccines Revenue by Region: 2027-2032
  8. 5.4 North America Influenza Drugs and Vaccines Market Facts & Figures by Country
  9. 5.4.1 North America Influenza Drugs and Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Influenza Drugs and Vaccines Sales by Country (2021-2032)
  11. 5.4.3 North America Influenza Drugs and Vaccines Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Influenza Drugs and Vaccines Market Facts & Figures by Country
  16. 5.5.1 Europe Influenza Drugs and Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Influenza Drugs and Vaccines Sales by Country (2021-2032)
  18. 5.5.3 Europe Influenza Drugs and Vaccines Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Influenza Drugs and Vaccines Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Influenza Drugs and Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Influenza Drugs and Vaccines Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Influenza Drugs and Vaccines Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Influenza Drugs and Vaccines Market Facts & Figures by Country
  41. 5.7.1 South America Influenza Drugs and Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Influenza Drugs and Vaccines Sales by Country (2021-2032)
  43. 5.7.3 South America Influenza Drugs and Vaccines Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Influenza Drugs and Vaccines Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Influenza Drugs and Vaccines Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Influenza Drugs and Vaccines Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Influenza Drugs and Vaccines Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Influenza Drugs and Vaccines Sales by Type (2021-2032)
  2. 6.1.1 Global Influenza Drugs and Vaccines Sales by Type (2021-2032) & (Tons)
  3. 6.1.2 Global Influenza Drugs and Vaccines Sales Market Share by Type (2021-2032)
  4. 6.2 Global Influenza Drugs and Vaccines Revenue by Type (2021-2032)
  5. 6.2.1 Global Influenza Drugs and Vaccines Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Influenza Drugs and Vaccines Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Influenza Drugs and Vaccines Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Influenza Drugs and Vaccines Sales by Application (2021-2032)
  2. 7.1.1 Global Influenza Drugs and Vaccines Sales by Application (2021-2032) & (Tons)
  3. 7.1.2 Global Influenza Drugs and Vaccines Sales Market Share by Application (2021-2032)
  4. 7.2 Global Influenza Drugs and Vaccines Revenue by Application (2021-2032)
  5. 7.2.1 Global Influenza Drugs and Vaccines Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Influenza Drugs and Vaccines Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Influenza Drugs and Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Influenza Drugs and Vaccines Value Chain Analysis
  2. 8.1.1 Influenza Drugs and Vaccines Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Influenza Drugs and Vaccines Production Mode & Process
  5. 8.2 Influenza Drugs and Vaccines Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Influenza Drugs and Vaccines Distributors
  8. 8.2.3 Influenza Drugs and Vaccines Customers
9 Global Influenza Drugs and Vaccines Analyzing Market Dynamics
  1. 9.1 Influenza Drugs and Vaccines Industry Trends
  2. 9.2 Influenza Drugs and Vaccines Industry Drivers
  3. 9.3 Influenza Drugs and Vaccines Industry Opportunities and Challenges
  4. 9.4 Influenza Drugs and Vaccines Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst